Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 16
Review
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
3,067 | Dovepress* | 2,439+ | 81 | 2,520 | |
PubMed Central* | 628 | 224 | 852 | ||
Totals | 3,067 | 305 | 3,372 | ||
*Since 18 September 2023 |
View citations on PubMed Central and Google Scholar